Table of Content - Genome Engineering Market

Global genome engineering market is estimated to be valued at USD 6.71 Bn in 2024, and is expected to exhibit a CAGR of 14.5% during the forecast period (2024-2031). Genome engineering, also known as genetic engineering, is a set of technologies that enable genetic manipulation and editing of an organism's genes. It involves the alteration of an organism's genetic makeup, including the transfer of genes within and across species boundaries to produce improved or novel organisms. Genome engineering utilizes technologies such as CRISPR/Cas9, TALENs, ZFNs and other DNA targeting nucleases to enable targeted genome editing and modification. Researchers have successfully utilized these technologies for crop improvement and experimental investigation of gene function in various organisms. Global genome engineering market is expected to witness growth due to increasing adoption of genome technologies in various industries.

Market Dynamics:

Global genome engineering market growth is driven by rising application of genetic engineering in areas of biotechnology, pharmaceuticals and agriculture. Genome editing tools such as CRISPR have provided researchers unparalleled precision to easily alter DNA sequences and modify gene function, fueling growth opportunities. Growing investment by key players and governments in genome engineering-based research can drive the market growth. However, uncertainties related to safety and ethics of human gene editing can pose a challenge to market players. Increasing R&D for developing more accurate and efficient genome engineering tools is expected to offer new opportunities for the market growth. Exploration of novel applications areas such as environmental remediation and energy production also hold immense potential for market growth in the near future.

Key Features of the Study:

This report provides an in-depth analysis of the global genome engineering market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global genome engineering market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Cellectis S.A., Merck KGaA, New England Biolabs, Agilent Technologies, Inc., Genscript, Synbio Technologies, Creative Biogene, Eurofins Scientific, Regeneron Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global genome engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genome engineering market.

Detailed Segmentation-

By Technology:
- CRISPR
- TALEN
- ZFN
- Others
By Application:
- Cell Line Engineering
- Genetic Engineering
By End User:
- Biotechnology & Pharmaceutical Companies
- Research Institutes
- Contract Research Organizations
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Company Profiles:

Thermo Fisher Scientific Inc.
CRISPR Therapeutics AG
Intellia Therapeutics, Inc.
Editas Medicine, Inc.
Sangamo Therapeutics, Inc.
Bluebird Bio, Inc.
Cellectis S.A.
Merck KGaA
New England Biolabs
Agilent Technologies, Inc.
Genscript
Synbio Technologies
Creative Biogene
Eurofins Scientific
Regeneron Pharmaceuticals Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Technology
  - Market Snapshot, By Application
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Genome Engineering Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
Global Genome Engineering Market, By Technology, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- CRISPR
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- TALEN
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- ZFN
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Genome Engineering Market, By Application, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Cell Line Engineering
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Genetic Engineering
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Genome Engineering Market, By End User, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Biotechnology & Pharmaceutical Companies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Research Institutes
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Contract Research Organizations
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Genome Engineering Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Region, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Thermo Fisher Scientific Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - CRISPR Therapeutics AG
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Intellia Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Editas Medicine, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sangamo Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Bluebird Bio, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Cellectis S.A.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Merck KGaA
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - New England Biolabs
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Agilent Technologies, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Genscript
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Synbio Technologies
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Creative Biogene
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Eurofins Scientific
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Regeneron Pharmaceuticals Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Genome Engineering Market” - Global forecast to 2031

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE